Malignant Uterine Neoplasm — Trials

Malignant Uterine Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,291 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 824
Recruiting: 456
Ph III recruiting: 55
Growth YoY: −3.6%
Industry share: 24%
Top sponsor: National Cancer Institute (NCI)
Termination share: 25.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (333)

clinicaltrialsPublishedShowing 1,301–1,311 of 1,311 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00156208	Safety of Treatment of Uterine Fibroids With Asoprisnil	completed	Phase 3	166	AbbottINDUSTRY	0	May 29, 2008	clinicaltrials
NCT00156156	Study of Asoprisnil in the Treatment of Uterine Fibroids.	completed	Phase 3	149	AbbottINDUSTRY	0	May 28, 2008	clinicaltrials
NCT00612495